catalyst

A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japane — primary completion

as of 2026-07-01
at a glance
2028-09-23 · Estimated (est.)Registry-estimated date, not yet actual.
Synthesized from structured facts only — each point cited above.

Event

What
A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japane — primary completion
Type
Trial Readout
Date
2028-09-23
Date type
ESTIMATED est.
Phase
Phase 3
Registry-estimated date, not yet actual. This date is directional and must not be read as settled.